How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology.
Key Topics Covered:
• ALK-positive lung cancer
• Cellular Therapy
• Vaccines
Guests:
Vincent Lam, MD
Associate Professor of Oncology, Johns Hopkins University School of Medicine
Director, Thoracic Oncology Clinical Research Program
Sidney Kimmel Comprehensive Cancer Center
Carmen Mecca. PhD
Postdoctoral Fellow, Chiarle Lab
Department of Pathology
Boston Children’s Hospital
Podden och tillhörande omslagsbild på den här sidan tillhör
IASLC. Innehållet i podden är skapat av IASLC och inte av,
eller tillsammans med, Poddtoppen.
